Adapting to Disruption of Pragmatic Clinical Trials Studying Nonpharmacological Approaches to Pain Management during the COVID-19 Pandemic: Lessons Learned from the NIH-DOD-VA Pain Management Collaboratory
Brian Coleman, DC
Seminar date: 11/3/2020
Description: The National Institutes of Health-Department of Defense-Department of Veterans Affairs Pain Management Collaboratory supports 11 large-scale, multisite, embedded pragmatic clinical trials in military and veteran health systems. As a result of the COVID-19 pandemic, the way we deliver nonpharmacological pain interventions has changed, prompting that we recognize and respond to shifting needs in patient care and clinical research. Pragmatic clinical trials are well suited in many ways to adapt to disruption, like that caused by the COVID-19 pandemic, but researchers should be sensitive to potential mediation of treatment effects caused by these disruptions. In this presentation, we share the initial findings of the actual and potential impacts of the COVID-19 pandemic on the operations of the Pain Management Collaboratory and the outcomes of its pragmatic clinical trials.